• Mon, August 5, 2024
Oren Livnat Maintained (zvra) at Strong Buy with Increased Target to $18 on, Aug 5th, 2024
Oren Livnat of HC Wainwright & Co., Maintained "Zevra Therapeutics, Inc." (ZVRA) at Strong Buy with Increased Target from $15 to $18 on, Aug 5th, 2024.
Oren, nor any peers, have made any analyst calls on ZVRA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30Like: 👍
